GFPC
HAE icon

Global Financial Private Client’s Haemonetics HAE Stock Holding History

Global Financial Private Client’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6
Closed -$381 – 787
2025
Q1 		$381 Buy
6
+4
+200% +$272 ﹤0.01% 1376
2024
Q4 		$156 Buy
+2
New +$161 ﹤0.01% 1359

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Global Financial Private Client's HAE Position: Q2 2025 in Review

Global Financial Private Client sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 6 shares — an estimated $381 sold.

Global Financial Private Client first reported a position in HAE in Q4 2024 and held it in 2 quarters. The position peaked at $381 in Q1 2025. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Global Financial Private Client reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 6 Haemonetics shares in Q2 2025, an estimated $381.
  • Global Financial Private Client first reported a position in Haemonetics in Q4 2024 and held it in 2 quarters.
  • Global Financial Private Client's Haemonetics position peaked at $381 in Q1 2025.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.